Pakistan faces one of the most severe breast cancer burdens in Asia. With a population of approximately 240 million, it is estimated that around 90,000 women are diagnosed with breast cancer every year — a figure that places Pakistan among the countries with the highest age-standardised breast cancer incidence rates in Asia, according to data from the Global Cancer Observatory (GLOBOCAN). More alarmingly, Pakistan has one of the highest breast cancer mortality-to-incidence ratios in the region, meaning that a far higher proportion of women diagnosed with breast cancer in Pakistan will die from it than women diagnosed in the UK or other high-income countries.
This is not primarily a biological difference. It is a consequence of late diagnosis, limited access to treatment and persistent cultural barriers to seeking care — all of which are addressable with the right investment and awareness.
The scale of the problem — Pakistan's breast cancer statistics
- Pakistan has the highest breast cancer incidence in Asia, estimated at approximately 2.5 times the rate of neighbouring India (age-standardised).
- Approximately 90,000 new cases are diagnosed annually, according to GLOBOCAN 2022 estimates.
- An estimated 40,000 women die from breast cancer in Pakistan every year.
- Fewer than 30% of breast cancers in Pakistan are diagnosed at stage I or II — when treatment is most effective. The majority present at stage III or IV.
- Five-year survival rates for breast cancer in Pakistan are estimated at 30–50%, compared to 87% in the UK.
- Women in Pakistan are diagnosed with breast cancer at a younger average age than in Western Europe — often in their 40s rather than their 50s and 60s.
Why is breast cancer so prevalent in Pakistan?
The reasons for Pakistan's elevated breast cancer incidence are not fully understood, but several factors are likely to contribute. Reproductive patterns — historically a protective factor (more children, more breastfeeding) — are changing as urbanisation increases and family sizes decrease in cities. Genetic factors may also play a role; studies have found a relatively high prevalence of BRCA1 and BRCA2 mutations in Pakistani women with breast cancer, with some founder mutations appearing at higher frequencies than in European populations.
Dense breast tissue — which is more common in younger women and certain ethnic populations — is associated with higher breast cancer risk and also makes mammography less sensitive. This may contribute to delayed detection in Pakistan's relatively young breast cancer patient population.
The barriers to early diagnosis
Pakistan's breast cancer mortality crisis is driven overwhelmingly by late diagnosis. The following factors contribute to women presenting at advanced stages:
- Stigma: Breast cancer carries significant social stigma in Pakistan. Women fear that a cancer diagnosis will harm their own or their daughters' marriage prospects. Many conceal symptoms from family members, delaying medical help by months or years.
- Lack of awareness: Many women in rural Pakistan — and some in urban areas — are not aware that a breast lump is a symptom requiring immediate medical attention. Breast self-examination is rarely taught in schools or health settings.
- Absence of a national screening programme: Pakistan does not have a national organised breast cancer screening programme comparable to the NHS Breast Screening Programme in the UK. In the absence of systematic screening, most breast cancers are detected only when symptoms become unavoidable.
- Access to diagnostic facilities: Mammography and pathology services are concentrated in major cities — Karachi, Lahore, Islamabad. Women in rural areas, who make up the majority of Pakistan's population, may need to travel for days to access diagnostic facilities.
- Cost: Even when diagnostic services exist, the cost of a biopsy, mammogram and subsequent treatment can be prohibitive for the majority of Pakistani households. Pakistan's healthcare system is largely private, with limited public funding for cancer care.
- Cultural norms around male doctors: Many women in Pakistan are uncomfortable being examined by male doctors and may avoid seeking care if a female physician is not available.
What is being done — and what more is needed
Pakistani oncologists, NGOs and international organisations have been working to improve breast cancer outcomes. The Pink Ribbon Pakistan foundation has established the country's first dedicated breast cancer hospitals in Lahore and Islamabad, providing low-cost screening and treatment. Community health workers have been trained to conduct breast cancer awareness sessions in rural communities. The Aga Khan University Hospital in Karachi operates one of the most advanced cancer treatment centres in the region.
However, these efforts reach only a fraction of the women who need them. A nationally coordinated screening programme, training of more female health workers, and investment in rural diagnostic capacity are all urgently required. Internationally, organisations like ours contribute by funding mobile screening clinics and clinical examination services in communities with no other access to breast cancer detection.
BRCA mutations and Pakistan's genetic landscape
Multiple studies from Pakistan's academic medical centres have found a relatively high frequency of BRCA1 and BRCA2 mutations among Pakistani women with breast cancer — particularly those with a family history or early-onset disease. Specific founder mutations (recurring mutations inherited from a common ancestor) have been identified that may be more prevalent in South Asian populations than previously appreciated.
For Pakistani and South Asian diaspora women in the UK who have a family history of breast or ovarian cancer, this reinforces the importance of asking a GP about genetic counselling and testing. BRCA testing is available free on the NHS for eligible individuals. See our guide on genes and family history for more information.
What Pakistani and South Asian women in the UK should do
- Attend your NHS breast screening invitations promptly when you are in the eligible age group (50–71).
- Practice breast self-examination regularly. Know what is normal for your breasts, so any change is noticed quickly.
- Do not delay seeing a GP if you notice a lump, skin change, nipple change or any other unusual symptom. You are entitled to an urgent two-week referral to a breast clinic.
- If you have a family history of breast or ovarian cancer — particularly at a young age or in multiple relatives — ask your GP about genetic counselling.
- Talk about it. Breaking the cultural silence around breast cancer is one of the most powerful preventive actions a community can take.
